HRZN vs PEBK

HRZN exhibits severe financial deterioration, highlighted by a weak Piotroski F-Score of 2/9 and a bearish technical trend of 0/100. While the stock trades at a discount to book value (P/B 0.65), this is offset by negative revenue growth (-12.20%) and a catastrophic dividend payout ratio of 224.56%. The company is effectively paying out more than it earns, signaling an imminent dividend cut. Despite a modest analyst target of $5.50, the fundamental trajectory is sharply negative.

PEBK presents a complex profile with a stable Piotroski F-Score of 4/9 and a current price ($41.92) trading below its Graham Number ($49.16), suggesting a value-based entry point. While the company shows strong historical price performance and a healthy ROE of 13.79%, these are heavily offset by a catastrophic recent YoY EPS decline of 580% and a poor earnings surprise track record. The divergence between the high intrinsic value estimate and the bearish insider sentiment suggests a potential peak in price despite the low P/E ratio. Overall, the stock is fundamentally undervalued but currently faces severe earnings volatility and negative internal sentiment.